BACOD regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: BACOD; BLEO/CTX/DM/DOX/VCR; Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Vincristine regimen
Overview
Overview
BACOD regimen refers to an immunochemotherapy regimen consisting of bleomycin, doxorubicin, cyclophosphamide ,vincristine ,dexamethasone used to treat relapsed and refractory diffuse large B cell lymphoma .[1][2]
Regimen
Regimen
BBleomycin
ADoxorubicin (Adriamycin)
CCyclophosphamide
OVincristine (Oncovin)
DDexamethasone
References
References
- ↑ “NCI Thesaurus”.
- ↑ “R-CHOP – National Cancer Institute”.
- ↑ Gong G, Du J, Dong L, Lei W, Gao X, Fang B; et al. (2014). “[Efficacy of adjusted BACOD regimen on the treatment of relapsed refractory diffuse large B cell lymphoma]”. Zhonghua Xue Ye Xue Za Zhi. 35 (4): 295–9. doi:10.3760/cma.j.issn.0253-2727.2014.04.010. PMID 24759015.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
